|
More
Healthcare Business Intelligence
Research Library
|
|
ActiveStrategy
|
"Strategy Execution vs. Business Intelligence: 101 Things BI Doesn't Do to Support a Performance Culture" is intended to help those in IT and business positions to more clearly understand the distinctions between ActiveStrategy and BI suite vendors. It provides a list of 101 functional differences that illustrate what might, at first glance, appear to be subtle differences, but are in reality ...
|
|
|
Solidiance
|
Solidiance examines the current market and implications for growth
Solidiance examines the current market and implications for growth
Solidiance examines the current market and implications for growth
Since Vietnam's admission to the World Trade Organization (WTO) in January 2007, the country has seen numerous and diverse changes that have propelled it into double-digit growth.
Structural ...
|
|
|
dbMotion
|
The medical world is making astounding, constant progress. Tools available to caregivers are continually improving, increasing diagnosis and treatment options. This trend has significantly increase total patient medical data. Concurrently, patients are becoming increasingly mobile and seeing more caregivers than in the past. Together, these trends have resulted in numerous partial medical records ...
|
|
|
Archimedes Inc.
|
Case: This project calculated the expected effect on health and economic outcomes of a proposed new program for managing people with diabetes in Kaiser Permanente, called "A-L-L". The Model predicted that the A-L-L program would simultaneously improve the health of Kaiser Permanente's members while also saving an estimated $38 million annually in unnecessary healthcare costs. Given the outcomes ...
|
|
|
Archimedes Inc.
|
Case: This project calculated the expected event rate in a control population of patients at risk for a Major Adverse Cardiac Event (MACE).
Conclusion: This information enabled a major pharmaceutical company to tune the enrollment optimally in a clinical trial evaluating a candidate compound targeting a novel cardiovascular biomarker.
Working closely with the client, Archimedes simulated the ...
|
|
|
|
